Erythropoietin and Neonatal Neuroprotection

Sandra E Juul1, Gillian C Pet1

  • 1Division of Neonatology, Department of Pediatrics, University of Washington, 1959 Northeast Pacific Street, Box 356320, Seattle, WA 98195-6320, USA.

Insights

Certain newborns face high risks of neurodevelopmental impairment and may benefit from neuroprotection. Erythropoietin (Epo) shows potential as a neuroprotective agent for neonatal brain injury, with ongoing clinical trials in infants.

Area of Science:

  • Neonatal neurology
  • Neuroprotection
  • Developmental neuroscience

Background:

  • Specific neonate groups are susceptible to long-term neurodevelopmental impairment.
  • Understanding neonatal brain injury mechanisms is crucial for effective interventions.
  • Cellular injury and death pathways in the neonatal brain require detailed investigation.

Purpose of the Study:

  • To identify high-risk neonatal groups for neurodevelopmental impairment.
  • To explore mechanisms underlying neonatal brain injury and cellular damage.
  • To discuss the neuroprotective potential of erythropoietin (Epo) in neonates.

Main Methods:

  • Review of high-risk neonatal populations.
  • Analysis of neonatal brain injury mechanisms.
  • Examination of cellular injury and death processes.
  • Discussion of erythropoietin's (Epo) role in neuroprotection.

Main Results:

  • Identified specific neonatal groups at high risk for neurodevelopmental deficits.
  • Elucidated key mechanisms of brain injury and cellular demise in neonates.
  • Erythropoietin (Epo) presents a promising therapeutic avenue for neonatal neuroprotection.

Conclusions:

  • Erythropoietin (Epo) holds significant potential for protecting the neonatal brain.
  • Further clinical investigation is warranted to confirm Epo's efficacy in preterm and term infants.
  • Targeted neuroprotective strategies are essential for high-risk neonates.

Related Concept Videos

Erythropoiesis01:14

Erythropoiesis

Red blood cells  (RBCs) transport oxygen to all body tissues. These cells survive only for 120 days and then need to be replenished. Erythropoiesis is the process of RBC production. In healthy individuals, erythropoiesis ensures all tissues are amply supplied with oxygen. In addition, blood loss due to injury leads to a drop in the physiological oxygen level that will cause erythropoiesis. Any defect in erythropoiesis leads to several physiological disorders, including thalassemia, anemia,...
6.9K
Role of Hematopoietic Growth Factors01:28

Role of Hematopoietic Growth Factors

Hematopoietic growth factors are molecules that regulate the differentiation rate of hematopoietic stem cells (HSCs). Erythropoietin (EPO), primarily produced by the kidneys, plays a crucial role in erythrocyte production. When oxygen levels in the blood are low, EPO is released into the bloodstream, reaching the bone marrow, where it stimulates HSCs to differentiate and mature into erythrocytes, which are vital for oxygen transport.
Thrombopoietin (TPO), mainly released by the liver,...
4.4K
Neurogenesis and Regeneration of Nervous Tissue01:15

Neurogenesis and Regeneration of Nervous Tissue

In the CNS, neurogenesis, the birth of new neurons from stem cells, is limited to the hippocampus in adults. In other regions of the brain and spinal cord, neurogenesis is almost non-existent due to inhibitory influences from neuroglia, especially oligodendrocytes, and the absence of growth-stimulating cues. The myelin produced by oligodendrocytes in the CNS inhibits neuronal regeneration. Furthermore, astrocytes proliferate rapidly after neuronal damage, forming scar tissue that physically...
2.1K
Factors Affecting Erythropoiesis01:24

Factors Affecting Erythropoiesis

The cardiovascular system regulates the number of erythrocytes in the bloodstream to ensure optimal oxygen transport. It also prevents over-proliferation of these cells, which helps to maintain blood viscosity and flow rate.
Several factors influence the erythrocyte production rate, with tissue oxygen level being among the most critical. Intense exercise or high altitudes can cause tissue hypoxia, which triggers the kidneys to release more erythropoietin (EPO) into the bloodstream.
EPO then...
7.5K